الفهرس 
HEMANGIOMAOnly 14 pages are availabe for public view
 |  | from | 121 |  |  |
| | | from | 121 | | |
Abstract
Infantile hemangiomas are the most common benign tumor during infancy. They are more common in females, premature infants and multiple pregnancies. IHs are characterized by rapid growth during the first year of life then gradual regression that is usually completed at 7-10 years.Most IHs are uncomplicated and don’t require treatment. However some hemangiomas require treatment for disfigurement, ulceration or life threatening locations.Propranolol is a non-selective beta blocker that blocks both β1 and β2 receptors. The role of propranolol in the treatment of IHs depends on vasoconstriction, inhibition of angiogenesis and induction of apoptosis.So, the aim of this work was to evaluate the efficacy and safety of oral propranolol in the treatment of infantile hemangiomas.This study included 10 cases of infantile hemangiomas. They were collected from the Outpatient Clinic of Dermatology and Venereology Department, Tanta University Hospital during the period from October 2013 to April 2014.